Translational Medicine and Oncologists Meet

Biography

Deepak Sampath joined Genentech in 2006 in the Oncology Department’s in vivo pharmacology group. Prior to Genentech, HE was a Principle Scientist at Wyeth Research in the Department of Oncology focusing on the discovery and preclinical pharmacology of novel anti-microtubule agents. Since joining Genentech he have worked on small molecule drug discovery programs focusing on two areas of interest that include targeting the PI3K pathway and Bcl-2 family of pro-survival proteins.

Research Interest

Translational Oncology, Drug discovery